WO2022184178 - KRAS G12D INHIBITORS
National phase entry is expected:
Publication Number
WO/2022/184178
Publication Date
09.09.2022
International Application No.
PCT/CN2022/079487
International Filing Date
07.03.2022
Title **
[English]
KRAS G12D INHIBITORS
[French]
INHIBITEURS DE KRAS G12D
Applicants **
JACOBIO PHARMACEUTICALS CO., LTD.
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
Inventors
HAN, Huifeng
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
GAO, Panliang
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
MA, Cunbo
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
WANG, Peng
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
LONG, Wei
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
WANG, Yanping
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
ZHANG, Hao
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
LIU, Dan
Unit 2
Building 5, BYBP, No.88 Kechuang Street 6th, Business Development Area Daxing
Beijing 101111, CN
Priority Data
PCT/CN2021/079415
05.03.2021
CN
PCT/CN2021/079448
06.03.2021
CN
PCT/CN2021/080222
11.03.2021
CN
PCT/CN2021/080572
12.03.2021
CN
PCT/CN2021/080599
12.03.2021
CN
PCT/CN2021/084322
31.03.2021
CN
PCT/CN2021/093764
14.05.2021
CN
PCT/CN2021/100187
15.06.2021
CN
PCT/CN2021/101089
18.06.2021
CN
PCT/CN2021/101188
21.06.2021
CN
PCT/CN2021/108808
28.07.2021
CN
PCT/CN2021/114094
23.08.2021
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
CNIPA
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2957 | |
| EPO | Filing, Examination | 16708 | |
| Japan | Filing | 594 | |
| South Korea | Filing | 934 | |
| USA | Filing, Examination | 8760 |
Total: 29953 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
Provided are KRAS G12D inhibitors of formula (I) or formula (IV), a composition containing the inhibitor and the use thereof.[French]
L'Invention concerne des inhibiteurs de KRAS G12D de formule (I) ou de formule (IV), une composition contenant l'inhibiteur et leur utilisation.